Search

Search Results

• The Prognostic Value of Positron Emission Tomography Findings in the Treatment of Primary Mediastinal (Thymic) Large B-Cell Lymphoma

  A.S. Subbotin, Arman Vachakanovich Arakelyan, G.S. Tumyan, V.V. Solomyanyi, B.M. Khakulova, A.A. Semenova, M.Yu. Kichigina, I.Z. Zavodnova, V.O. Shpirko, Yu.I. Klyuchagina, S.F. Ramazanova, U.G. Koshkina, O.P. Trofimova, M.A. Senchenko, V.Yu. Kirsanov

  326-339

  01.10.2025

• Bone Marrow Lymphocyte Subpopulation in Chronic Lymphocytic Leukemia Patients with Different Responses to Chemotherapy

  Olesya Nikolaevna Selyutina, E.Yu. Zlatnik, N.K. Guskova, I.A. Novikova, I.B. Lysenko, A.B. Sagakyants, T.F. Pushkareva, L.Yu. Vladimirova

  376-383

  01.10.2024

• The Prognostic Value of Cytotoxic CD8-Positive Т-Lymphocytes of the Reactive Tumor Microenvironment in Diffuse Large B-Cell Lymphoma

  Elena Viktorovna Vaneeva, V.A. Rosin, D.A. Dyakonov, N.V. Glubokovskikh

  266-272

  01.07.2024

• Treatment of Patients with Local Stages of Newly Diagnosed Classical Hodgkin Lymphoma: A Literature Review, Current Approaches, and Our Own Experience

  Evgeniya Viktorovna Paramonova, Yu.I. Klyuchagina, M.Yu. Kichigina, D.N. Tupitsyna, V.O. Shpirko, A.V. Arakelyan, A.A. Semenova, E.A. Demina, O.P. Trofimova, A.S. Subbotin, M.A. Senchenko, G.S. Tumyan

  27-36

  17.05.2024

• Follicular Lymphoma of Grades 1–3А With and Without t(14;18)(q32;q21): A Prognosis, Choice of Chemotherapy and Its Outcomes

  Ekaterina Sergeevna Nesterova, E.E. Zvonkov, A.M. Kovrigina, T.N. Obukhova, B.V. Biderman, A.B. Sudarikov, Ya.K. Mangasarova, A.U. Magomedova, A.K. Smolyaninova, S.M. Kulikov, E.N. Parovichnikova

  361-369

  28.09.2023

• Expression of the WNT Family Genes in Multiple Myeloma Patients with Different Chemotherapy Response

  Natella Iosifovna Enukashvili, L.A. Belik, I.I. Kostroma, N.Yu. Semenova, V.A. Balashova, D.V. Baram, S.V. Gritsaev, S.S. Bessmeltsev, S.V. Sidorkevich, I.S. Martynkevich

  294-302

  09.06.2023

• Approaches to the Treatment of Patients with Myelofibrosis and Polycythemia Vera with Constitutional Symptoms in Real-World Clinical Practice in the Russian Federation: Intermediate Results of a Multi-Center Observational Prospective Clinical Study

  Anait Levonovna Melikyan, I.N. Subortseva, S.M. Kulikov, Yu.A. Chabaeva, E.A. Gilyazitdinova, K.P. Novoselov, E.A. Knyazeva, A.S. Egorova, I.S. Stepochkin, E.V. Koroleva, T.M. Sycheva, V.P. Belgesova, A.Yu. Putintseva, O.M. Senderova, I.V. Vasil’eva, E.Yu. Komartseva, A.A. Kaplina, V.I. Bakhtina, M.A. Mikhalev, Yu.B. Chernykh, E.N. Parovichnikova

  146-153

  03.03.2023

• Protocol ALL-IC BFM 2002: Outcomes of Pediatric Acute Lymphoblastic Leukemia Treatment under Multi-Center Clinical Trial

  Timur Teimurazovich Valiev, M.A. Shervashidze, I.V. Osipova, T.I. Burlutskaya, N.A. Popova, N.S. Osmulskaya, G.A. Aleskerova, S.L. Sabantsev, Z.S. Gordeeva, V.Yu. Smirnov, O.A. Poberezhnaya, S.N. Yuldasheva, I.A. Babich, N.A. Batmanova, S.R. Varfolomeeva

  119-129

  01.04.2022

• Results of the Russian Multi-Center Cooperative Prospective-Retrospective Observational Program for Hodgkin’s Lymphoma Treatment RNWOHG-HD1

  Ivan Sergeevich Moiseev, S.M. Alekseev, N.B. Mikhailova, K.D. Kaplanov, M.V. Demchenkova, L.V. Anchukova, V.V. Baikov, A.M. Belyaev, Yu.A. Vasil’eva, N.P. Volkov, Yu.N. Vinogradova, A.Yu. Zaritskey, A.E. Zdorov, N.V. Il’in, L.O. Kashintseva, E.V. Kondakova, P.V. Kotselyabina, V.A. Lapin, K.V. Lepik, I.V. Lesechko, V.M. Moiseenko, G.M. Manikhas, N.V. Medvedeva, Yu.A. Oleinik, E.S. Pavlyuchenko, K.S. Parfenova, E.V. Patrakova, A.V. Proidakov, D.V. Saidullaeva, E.V. Tarasova, A.L. Shipaeva, T.V. Shneider, B.V. Afanasyev

  455-465

  01.10.2021

• Ibrutinib as First-Line Therapy in High-Risk Chronic Lymphocytic Leukemia: Case Reports

  Nadezhda Viktorovna Kurkina, E.A. Repina

  488-495

  01.10.2021

• Value of PD-L1 Protein Expression in the Combined Prognostic Model of Diffuse Large B-Cell Lymphoma

  Svetlana Valerevna Samarina, N.Yu. Semenova, N.V. Minaeva, D.A. Dyakonov, V.A. Rosin, E.V. Vaneeva, S.V. Gritsaev

  308-314

  01.07.2021

• Obesity as a Poor Prognostic Factor in Multiple Myeloma

  Evgenii Sergeevich Mikhailov, G.N. Salogub, S.S. Bessmeltsev

  315-320

  01.07.2021

• Factors for Sustaining Molecular Remission after Discontinuation of Tyrosine Kinase Inhibitors Therapy in Chronic Myeloid Leukemia: Results of Non-Randomized Prospective Clinical Trial

  Oleg Aleksandrovich Shukhov, A.N. Petrova, E.Yu. Chelysheva, A.V. Bykova, I.S. Nemchenko, A.G. Turkina

  1-12

  01.01.2021

• Pattern of Immunocompetent Peripheral Blood Cell Subpopulations in B-Cell Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

  E.G. Kuzmina, T.Yu. Mushkarina, T.V. Konstantinova, Svetlana Valer’evna Zatsarenko, S.V. Shakhtarina, A.Yu. Terekhova, N.A. Falaleeva, L.Yu. Grivtsova

  395-405

  01.10.2020

• Immunohistochemical Subtype and Parameters of International Prognostic Index in the New Prognostic Model of Diffuse Large B-Cell Lymphoma

  S.V. Samarina, A.S. Luchinin, N.V. Minaeva, I.V. Paramonov, D.A. D’yakonov, E.V. Vaneeva, V.A. Rosin, S.V. Gritsaev

  385-390

  01.10.2019

• Infectious Complications after Haploidentical Hematopoietic Stem Cells Transplantation in Patients with High-Risk Tumors of Hematopoietic and Lymphoid Tissues: A Single-Center Experience

  Yurii Sergeevich Osipov, S.S. Bessmeltsev, G.N. Salogub, V.V. Ivanov, E.S. Mikhailov, N.A. Zhukova, A.V. Chechetkin

  406-415

  01.10.2019

• Expression of Adhesion Molecule CD56 in Tumor Plasma Cells in Bone Marrow as a Prognostic Factor in Multiple Myeloma

  Maiya Valer’evna Firsova, L.P. Mendeleeva, A.M. Kovrigina, M.V. Solov’ev, N.L. Deineko, M.Yu. Drokov, V.G. Savchenko

  377-384

  01.10.2019

• Current Genetic Models for Prediction of Primary Myelofibrosis

  Lyubov Borisovna Polushkina, V.A. Shuvaev, M.S. Fominykh, Yu.A. Krivolapov, E.A. Belyakova, Z.P. Asaulenko, E.V. Motyko, L.S. Martynenko, M.P. Bakai, N.Yu. Tsybakova, S.V. Voloshin, S.S. Bessmeltsev, A.V. Chechetkin, I.S. Martynkevich

  391-397

  01.10.2019

• Prediction of FLAG ± Ida Regimen Efficacy in Patients with Relapsed/Refractory Acute Myeloid Leukemia

  Irina Garmaevna Budaeva, E.G. Ovsyannikova, E.N. Goryunova, O.V. Kulemina, D.V. Zaitsev, D.V. Motorin, R.Sh. Badaev, D.B. Zammoeva, V.V. Ivanov, K.V. Bogdanov, O.S. Pisotskaya, Yu.V. Mirolyubova, T.S. Nikulina, Yu.A. Alekseeva, A.Yu. Zaritskey, L.L. Girshova

  289-296

  01.07.2019

• Analysis Results of the Regional Registry of Patients with Diffuse Large B-cell Lymphoma: Risk Factors and Chemo-Immunotherapy Issues

  Kamil’ Daniyalovich Kaplanov, N.P. Volkov, T.Yu. Klitochenko, I.V. Matveeva, A.L. Shipaeva, M.N. Shirokova, N.V. Davydova, E.G. Gemdzhian, D.S. Abramov, D.M. Konovalov, G.L. Snigur, N.A. Red’kina

  154-164

  01.04.2019

• Prognostic Value of PRAME Activity in Tumor Cells of Follicular Lymphoma

  Vsevolod Andreevich Misyurin, A.E. Misyurina, S.K. Kravchenko, N.A. Lyzhko, Yu.P. Finashutina, N.N. Kasatkina, D.S. Mar’in, E.S. Nesterova, N.N. Sharkunov, M.A. Baryshnikova, A.V. Misyurin

  173-178

  01.04.2019

• Clinical and Hematological Predictors of Response to First-Line Therapy in Patients with Diffuse Large B-Cell Lymphoma

  Svetlana Valer’evna Samarina, E.L. Nazarova, N.V. Minaeva, E.N. Zotina, I.V. Paramonov, S.V. Gritsaev

  68-72

  01.01.2019

• Evolution of Anti-Cancer Treatment and its Impact on Surrogate Prognostic Factors in Multiple Myeloma

  Aleksandr Sergeevich Luchinin, S.V. Semochkin, N.V. Minaeva, N.M. Pozdeev, I.V. Paramonov

  175-181

  01.04.2018

• Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma in the Era of New Drugs

  Ol’ga Vladislavovna Pirogova, E.I. Darskaya, V.V. Porunova, O.V. Kudyasheva, A.G. Smirnova, I.S. Moiseev, E.V. Babenko, B.V. Afanas’ev

  187-191

  01.04.2018

• Prognostic Value of Genetic Markers for Efficacy Estimation of Induction Treatment Including Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients

  Elena L’vovna Nazarova, N.V. Minaeva, M.N. Khorobrykh, E.E. Sukhorukova, V.I. Shardakov, I.V. Paramonov, N.A. Zorina

  54-69

  01.01.2018

• Prognostic Value and Correlation Between WT1 Overexpression and NPM1 Mutation in Patients with Acute Myeloblastic Leukemia

  L.L. Girshova, Irina Garmaevna Budaeva, E.G. Ovsyannikova, S.O. Kuzin, D.V. Motorin, R.Sh. Badaev, D.B. Zammoeva, V.V. Ivanov, K.V. Bogdanov, O.S. Pisotskaya, Yu.V. Mirolyubova, T.S. Nikulina, Yu.A. Alekseeva, A.Yu. Zaritskii

  485-493

  01.10.2017

• Acute Lymphoblastic Leukemia with t(4;11)(q21;q23)/KMT2A-AFF1 Translocation: The Results of Allogeneic Hematopoietic Stem Cells Transplantation in Children and Adults

  Tat’yana Leonidovna Gindina, N.N. Mamaev, O.V. Paina, A.S. Borovkova, P.V. Kozhokar’, O.A. Slesarchuk, Ya.V. Gudozhnikova, E.I. Darskaya, A.L. Alyanskii, S.N. Bondarenko, L.S. Zubarovskaya, B.V. Afanas’ev

  342-350

  01.07.2017

• V(D)J Recombination Excision Circles of B- and T-cells as Prognostic Marker in B-Cell Chronic Lymphocytic Leukemia

  Igor’ Vladimirovich Obraztsov, M.A. Gordukova, N.A. Severina, B.V. Biderman, S.Yu. Smirnova, A.B. Sudarikov, E.A. Nikitin, A.G. Rumyantsev

  131-140

  01.04.2017

• Evaluation of Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Using EuroFlow Approaches

  Ol’ga Alekseevna Beznos, L.Yu. Grivtsova, A.V. Popa, M.A. Shervashidze, I.N. Serebryakova, O.Yu. Baranova, E.A. Osmanov, N.N. Tupitsyn

  158-168

  01.04.2017

• Diagnostic and Prognostic Value of Biochemical Markers of Infectious Complications of High-Dose Therapy with Autologous Hematopoietic Stem Cell Transplantation in Malignant Lymphoproliferative Diseases

  Vladislav Olegovich Sarzhevskii, Yu.N. Dubinina, V.Ya. Mel’nichenko

  113-119

  01.01.2017

• Rearrangement of 11q23 Chromosome Region in Acute Myeloid Leukemias in Children

  Elena Vol’fovna Fleishman, O.I. Sokova, A.V. Popa, G.A. Tsaur, L.N. Konstantinova, O.M. Plekhanova, M.V. Strigaleva, E.S. Nokhrina, V.S. Nemirovchenko, O.R. Arakaev

  446-455

  01.10.2016

• Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemias: Prognostic Significance of Complex Karyotype Including del(5q), –7, del(7q) Abnormalities

  Tat’yana Leonidovna Gindina, N.N. Mamaev, S.N. Bondarenko, E.S. Nikolaeva, I.A. Petrova, O.A. Slesarchuk, A.S. Borovkova, S.V. Razumova, A.L. Alyanskii, L.S. Zubarovskaya, B.V. Afanas’ev

  271-278

  01.07.2016

• Role of Patient’s Age and Comorbidities in Therapy of Chronic Lymphocytic Leukemia

  Vladimir Vladimirovich Strugov, E.A. Stadnik, Yu.V. Virts, T.O. Silina, A.Yu. Zaritskii

  162-175

  01.04.2016

• Modern Aspects of Diagnosis and Treatment of Anaplastic Large Cell Lymphoma in Children (Literature Review)

  Andrei Sergeevich Levashov, T.T. Valiev, A.M. Kovrigina, A.V. Popa, G.L. Mentkevich

  199-207

  01.04.2016

• Analysis of Karyotype Aberrations in Children and Adolescents with Post-Transplantation Relapses of Acute Leukemia

  Tat’yana Leonidovna Gindina, N.N. Mamaev, E.N. Nikolaeva, I.A. Petrova, S.N. Bondarenko, A.L. Alyanskii, N.V. Stancheva, O.A. Slesarchuk, M.Yu. Aver’yanova, L.S. Zubarovskaya, B.V. Afanas’ev

  420-427

  01.10.2015

• Efficacy and Toxicity of Therapy for Patients with Intermediate-Risk Hodgkin’s Lymphoma: Results of Multicenter Randomized Study

  I.A. Kryachok, Alim Anvarovich Amdiev, I.B. Titorenko, E.M. Aleksik, E.O. Ul’yanchenko, O.I. Novosad, E.S. Filonenko, M.I. Kasich, M.Ya. Kiseleva

  281-286

  01.07.2015

• Efficacy of platelet transfusions during standard induction chemotherapy in patients with acute myeloid leukemia

  B. Davaasambuu, S.V. Gritsayev, T.V. Glazanova, S.A. Tiranova, N.A. Potikhonova, I.S. Martynkevtch, A.V. Chechetkin

  213-219

  01.04.2014

• Clinico-hematological and molecular genetic variability of acute myeloid leukemia with CD7 expression on blasts cells

  S.V. Gritsayev, Z.V. Chubukina, I.S. Martynkevich, I.I. Kostroma, T.V. Glazanova, Ye.V. Petrova, L.S. Martynenko, S.A. Tiranova, N.A. Potikhonova, I.S. Zyuzgin, L.N. Bubnova, K.M. Abdulkadyrov

  427-433

  01.10.2013

• International prognostic score in advanced Hodgkin’s lymphoma

  K.D. Kaplanov, A.L. Shipaeva, V.A. Vasil’yeva, E.G. Gemdjian, I.V. Matveeva, L.S. Tregubova, T.U. Klitochenko, K.V. Demidenko, O.B. Kalashnikova, G.U. Vyskub, O.E. Golubeva, O.V. Levina, V.A. Orlov, E.A. Demina

  294-302

  01.07.2013

• Cytogenetic remission as an important criterion for treatment efficacy in pediatric acute myeloid leukemia

  E.W. Fleischman, O.I. Sokova, A.V. Popa, V.S. Nemirovchenko, L.N. Konstantinova, N.F. Metelkova

  148-156

  01.04.2013